DEDIFFERENTIATED LEIOMYOSARCOMA

Anggie Sasmita Kharisma  Putri; Diah Prabawati Retnani; Aina Angelina; Harun Al Rasyid; Karyono Mintaroem; Eviana Norahmawati; M Luqman Fadli

doi:10.30649/obj.v6i2.130

Authors

Anggie Sasmita Kharisma Putri Universitas Brawijaya
Diah Prabawati Retnani Staf Pengajar Patologi Anatomi, Fakultas Kedokteran Universitas Brawijaya-RSUD dr. Saiful Anwar
Aina Angelina Staf Pengajar Patologi Anatomi, Fakultas Kedokteran Universitas Brawijaya-RSUD dr. Saiful Anwar
Harun Al Rasyid Staf Pengajar Fakultas Kedokteran Universitas Brawijaya
Karyono Mintaroem Staf Pengajar Patologi Anatomi, Fakultas Kedokteran Universitas Brawijaya-RSUD dr. Saiful Anwar
Eviana Norahmawati Staf Pengajar Patologi Anatomi, Fakultas Kedokteran Universitas Brawijaya-RSUD dr. Saiful Anwar
M Luqman Fadli Staf Pengajar Patologi Anatomi, Fakultas Kedokteran Universitas Brawijaya-RSUD dr. Saiful Anwar

DOI:

https://doi.org/10.30649/obj.v6i2.130

Keywords:

meningioma, PR, MMP9

Abstract

Background: Meningioma is the most common intracranial tumor in adults. Progesterone plays a role in the cell development and proliferation of hormone-associated tumors, such as meningiomas. Significant morbidity and mortality can occur, when the lesion is localized in an area that is difficult to undergo surgical resection or is highly infiltrative in the surrounding tissue. Many studies have been published on the molecular properties associated with meningioma aggressive behavior, including matrix metalloproteinase (MMP), but research on the relationship between PR expression and MMP-9 has not been widely carried out.

Methods: This study used a cross-sectional analytic observational study design. The analysis used in this study includes descriptive analysis and bivariate analysis. The data obtained was processed using SPSS software.

Results: Spearman's correlation test for PR expression with WHO grading in meningioma, obtained p = 0.492 and correlation coefficient -0.117. This shows a correlation that is not significant. Spearman's correlation test for MMP expression with WHO grading in meningioma, obtained p = 0.16 and a correlation coefficient of 0.236. This shows a correlation that is not significant. Spearman's correlation test between MMP9 expression and WHO grading in meningioma obtained p = 0.008 which indicated that the correlation between PR and MMP9 values was significant with a correlation value of -0.427.

Conclusion: There is no significant correlation between PR expression and WHO grading. There was no significant correlation between MMP9 expression and WHO grading. There is a significant correlation between PR expression and MMP9.

References

Huntoon, K., Toland, A.M.S., and Dahiya, S. 2020. Meningioma: A Review of Clinicopathological and Molecular Aspects. Front. Oncol. 10, 579599.

Ostrom, Q.T.; Cioffi, G.; Gittleman, H.; Patil, N.; Waite, K.; Kruchko, C.; et al. 2019. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016. Neuro Oncol. 21, v1–v100.

Lassie, N. dan Supartoto, A. 2016. Progesterone Receptor Expression in Histopathological Subtypes of Beningn Orbitocranial Meningiomas. Ophthalmol Ina, 42(1), 91–96.

Zhao, L., Zhao, W., Hou, Y., Wen, C., Wang, J., Wu, P., et al. 2020. An Overview of Managements in Meningiomas. Frontiers in Oncology, 10 (August), 1–12. https://doi.org/10.3389/fonc.2020.01523.

Ozek, E., Ozcan, D., Celik, S. E., and Iplikcioglu, A. C. 2018. Matrix metalloprotease-9 expresssion in meningioma: Correlation with growth fraction and role of gender. A pilot immunohistochemical study. Clinical Neurology and Neurosurgery, 172, 169–173. https://doi.org/10.1016/j.clineuro.2018.07.002.

Baldi, I., Engelhardt, J., Bonnet, C., Bauchet, L., Berteaud, E., Grüber, A., et al, Epidemiology of meningiomas, Neuro-Chirurgie (2014), https://doi.org/10.1016/j. neuchi.2014.05.006.

Apriyani, V. 2021. Faktor Risiko Meningioma Orbitokranial Pada Wanita Pengguna Kontrasepsi Hormonal. Tesis. Tidak diterbitkan, Fakultas Kedokteran Universitas Padjajaran Bandung.

Lee, Y.S. Molecular Characteristics of Meningiomas. J. Pathol. Transl. Med. 2020;54:45–63. doi: 10.4132/jptm.2019.11.05.

Louis, D.N., Ohgaki, H., Wiestler, O.D., and Cavenee, W.K. WHO Classification of Tumours of the Central Nervous System; World Health Organization Classification of Tumours. 4th ed. International Agency for Research on Cancer; Lyon, France: 2016.

Perry, A, Meningioma. In: Perry A, Brat DJ, eds. Practical Surgical Neuropathology: A Diagnostic Approach. 2nd edition. Philadelphia: Elsevier; 2018:259–298.

Mnango, L., Mwakimonga, A., Ngaiza, A., Yahaya, J.J., Vuhahula, E., and Mwakigonja, A.R. 2021. Expression of Progesterone Receptor and Its Association with Clinicopathological Characteristics in Meningiomas: A Cross-Sectional Study. World Neurosurg X. Jul 14;12:100111. doi: 10.1016/j.wnsx.2021.100111. PMID: 34401742; PMCID: PMC8355943.

Hsu D.W., Efird J.T., Hedley-Whyte E.T. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg. 1997;86:113–120.

Roser F., Nakamura M., Bellinzona M., Rosahl S.K., Ostertag H., Samii M. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol. 2004;57:1033–1037.

Shayanfar N, Mashayekh M, Mohammadpour M. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma. Acta Med Iran. 2010 May-Jun;48(3):142-7. PMID: 21137648.

Kunimatsu A., Kunimatsu N., Kamiya K., Katsura M., Mori H., Ohtomo K. Variants of meningiomas: a review of imaging findings and clinical features. Jpn J Radiol. 2016;34:459–469.

Ramos-Vara, J.A. et al. (2014) ‘Immunohistochemical Evaluation of the Effects of Paraffin Section Storage on Biomarker Stability’, Veterinary Pathology, 51(1), pp. 102–109. Available at: https://doi.org/10.1177/0300985813476067.

Backer-Grøndahl, T., Moen, B.H., Arnli, M.B., Torseth, K., and Torp, S.H. 2014. Immunohistochemical characterization of brain-invasive meningiomas. International Journal of Clinical and Experimental Pathology, 7(10), pp. 7206–7219.

Barresi, V., Alafaci, C., Caffo, M., Barresi, G., and Tuccari, G. 2012. Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas. Pathology Research and Practice, 208(6), pp. 350–355. Available at: https://doi.org/10.1016/j.prp.2012.02.013.

Reszec, J., Hermanowicz, A., Rutkowski, R., Turek, G., Mariak, Z., and Chyczewski, L. Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema. Biomed Res Int. 2015; 2015:646853. doi: 10.1155/2015/646853. Epub 2015 Mar 3. PMID: 25821815; PMCID: PMC4363610.

Elhakeem, A.A.E., Essa, A.A., Soliman, R.K. Hamdan, A.R.K. Novel evaluation of the expression patterns CD44 and MMP9 proteins in intracranial meningiomas and their relationship to the overall survival. 2022. Egypt J Neurosurg 37, 33. https://doi.org/10.1186/s41984-022-00173-x.

Barresi, V., Alafaci, C., Caffo, M., Barresi, G., and Tuccari, G. 2012. Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas. Pathology Research and Practice, 208(6), pp. 350–355. Available at: https://doi.org/10.1016/j.prp.2012.02.013.

Wang, X., Zhang, J., Yang, Y., Dong, W., Wang, F., Wang, L., et al. 2013. Progesterone attenuates cerebral edema in neonatal rats with hypoxic-ischemic brain damage by inhibiting the expression of matrix metalloproteinase-9 and aquaporin-4. Experimental and Therapeutic Medicine, 6(1), 263–267. https://doi.org/10.3892/etm.2013.1116.